Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round as it seeks to take its drug candidates to clinical trials. The funding was co-led by Greenoaks and Sequoia Capital, with new investor Andreessen Horowitz and other investors also participating.
Demis Hassabis has issued a stern warning: a very powerful AI may be near and humanity needs to do more to prepare. In a short essay published on X and Substack on Tuesday, Google CEO DeepMind said there is a “precious window” to act before artificial general intelligence (AGI) arrives. AGI refers to AI that